Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)
Clinical trial NCT05559645 · UNKNOWN
Trial details
- NCT number
- NCT05559645
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2025-12-31
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.